.svg.png){kind=small}
.svg){kind=small}
A leader in artificial intelligence and healthcare technical services including algorithm development, data analysis, and image processing ever since 2001
Diagnos is rolling out their non-invasive AI health care technology to prescreen for diabetes-related blindness. This disruptive AI technology platform works seamlessly with current optometry equipment in a global market expected to double.
They have a product called CARA used for computer-assisted retinal analyses. What this product does is automatically analyze the retina, and it can spot damage caused by diabetes or cardiovascular issues. That said, Cara can actually save someone from going blind.
For more information on Diagnos (TSX.V: ADK) please click the request investor info button.
.png){kind=small}
